MRKR – marker therapeutics, inc. (US:NASDAQ)

DELAYED 04:36 PM EDT 03/28/25


Volume Shares
1 Day Range
Volume Ratio
52 Week High	9.6799 03/31/24
52 Week Low	0.6706 03/31/24


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MRKR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/5

08:08 am

mrkr

Marker Therapeutics, Inc. (NASDAQ: MRKR) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $8.00 price target on the stock.

High Report

Marker Therapeutics, Inc. (NASDAQ: MRKR) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $8.00 price target on the stock.

Report

2/25

08:04 am

mrkr

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference [Yahoo! Finance]

Medium Report

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference [Yahoo! Finance]

Report

2/25

07:00 am

mrkr

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Medium Report

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Report

2/12

07:46 am

mrkr

Marker Therapeutics, Inc. (NASDAQ: MRKR) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.

Low Report

Marker Therapeutics, Inc. (NASDAQ: MRKR) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.